09:35 AM EDT, 05/07/2026 (MT Newswires) -- Edgewise Therapeutics (EWTX) retreated more than 1% in morning trading Thursday as the company reported a wider Q1 loss.

The company reported a Q1 net loss of $0.46 per diluted share, compared with a loss of $0.43 a year earlier.

Four analysts polled by FactSet expected a loss of $0.49.

As expected, no revenue was reported for the quarter ended March 31.

The company said it had cash, cash equivalents and marketable securities of about $499.6 million as of March 31.

Price: 36.44, Change: -0.55, Percent Change: -1.48

Ämnen i artikeln

Edgewise Therapeutics

Senast

36,39

1 dag %

−1,62%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån